Hostname: page-component-89b8bd64d-7zcd7 Total loading time: 0 Render date: 2026-05-14T07:01:46.668Z Has data issue: false hasContentIssue false

S-100 protein and myoepithelial neoplasms

Published online by Cambridge University Press:  29 June 2007

J. G. Batsakis*
Affiliation:
Department of Pathology, University of Texas System Cancer centre, M. D. Anderson Hospital, Houston, Texas 77030.
N. G. Ordonez
Affiliation:
Department of Pathology, University of Texas System Cancer centre, M. D. Anderson Hospital, Houston, Texas 77030.
J. Ro
Affiliation:
Department of Pathology, University of Texas System Cancer centre, M. D. Anderson Hospital, Houston, Texas 77030.
J. M. Meis
Affiliation:
Department of Pathology, University of Texas System Cancer centre, M. D. Anderson Hospital, Houston, Texas 77030.
J. M. Bruner
Affiliation:
Department of Pathology, University of Texas System Cancer centre, M. D. Anderson Hospital, Houston, Texas 77030.
*
John G. Batsakis, M. D., Department of Pathology, M. D. Anderson Hospital, Houston, Texas 77030, U.S.A.

Abstract

Besides advancing our knowledge of histogenesis, immuno-cytochemical studies of salivery gland tumors have added an important objective component to the diagnosis and classification of the tumors. Cellular localization of S-100 protein now allows identification of myoepithelial cells and tumors composed of these cells. The four tumors presented in this report illustrate the diagnostic advantages afforded by S-100 protein immunocytochemistry.

Information

Type
Research Article
Copyright
Copyright © JLO (1984) Limited 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable